International Stem Cell (ISCO) Change in Inventory (2010 - 2025)
International Stem Cell (ISCO) posted quarterly Change in Inventory of -$71000.0 for Q4 2025, up 67.73% year-over-year from -$42330.6 in Q4 2024, and down 491.67% quarter-over-quarter from -$12000.0 in Q3 2025.
International Stem Cell (ISCO) Change in Inventory (2010 - 2025) Analysis & Trends
International Stem Cell (ISCO) has reported Change in Inventory for 16 consecutive years, with -$71000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Inventory rose 67.73% year-over-year to -$71000.0; the TTM figure through Dec 2025 stood at $387000.0 (up 439.47% YoY), while the FY2025 annual figure was $387000.0, up 439.47% from the prior year.
- Change in Inventory eased to -$71000.0 in Q4 2025 per ISCO's latest filing, from -$12000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $300000.0 in Q2 2025 and bottomed at -$220000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $30850.0 across 5 years, with a median of $24000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Inventory surged 687.5% — and 2024, when it sank 1592.31%.
- International Stem Cell's Change in Inventory stood at $52000.0 in 2021, then tumbled by 319.23% to -$114000.0 in 2022, then surged by 88.6% to -$13000.0 in 2023, then tumbled by 1592.31% to -$220000.0 in 2024, then jumped by 67.73% to -$71000.0 in 2025.
- Business Quant data shows ISCO's Change in Inventory at -$71000.0 in Q4 2025, -$12000.0 in Q3 2025, and $300000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | - |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -71,000.00 |
| Dec 31, 2025 | -71,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | -220,000.00 |
| Dec 31, 2024 | -220,000.00 |
| Sep 30, 2024 | -69,000.00 |
| Sep 30, 2024 | -69,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Sep 30, 2023 | -7,000.00 |